JDD HighlightsSkin of Color

View the Latest Skin of Color, Anti-Aging, Aesthetic, and Medical Dermatology Articles Now

By June 30, 2020July 9th, 2020No Comments

Dermatology News

JDD Highlights

The July issue of the Journal of Drugs in Dermatology is available now. This month, we focus on Skin of Color, with special features on Anti-Aging, Aesthetic, and Medical Dermatology.
Read the JDD Now

Skin of Color, Anti-Aging, Aesthetic, and Medical Dermatology

The July issue of the Journal of Drugs in Dermatology is available now. This month, we focus on Skin of Color, with special features on Anti-Aging, Aesthetic, and Medical Dermatology.

Article Highlights

Editor's Picks

You May Also Like

Journal of Drugs in Dermatology JDD About The Full Spectrum of Dermatology: A Diverse and Inclusive Atlas. The images is of sarcoidosis among different skin tones

Decoding Derm: What’s the Diagnosis?

| Featured Articles, Inclusive Dermatology Atlas, Latest News | No Comments
Test Your Knowledge! Join Dr. Alexis Carrington, Chief Dermatology Resident at George Washington University, to help understand dermatologic conditions across all skin tones. Decoding Derm: What’s the Diagnosis is a…

JDD Re:View With Dr. Beer

| Featured Articles, JDD Re:View, Latest News | No Comments
Title: Novel Treatments and Clinical Insights Shaping Dermatology As we head into the new year, it’s important to highlight some of the pieces that helped clarify the role of novel…
Journal of Drugs in Dermatology author Dr. Andrew Blauvelt speaking about cutting‑edge psoriasis science during George Washington University’s Dermatology Translational Science Lecture Series. The title of the presentation is Curing Psoriasis.

JDD Author and Psoriasis Expert Andrew Blauvelt, MD, MBA: Watch His “Curing Psoriasis” Translational Lecture Series

| Featured Articles, Latest News | No Comments
See JDD author Dr. Andrew Blauvelt bring cutting‑edge psoriasis science to life in GWU’s Dermatology Translational Science Lecture Series, and learn about his new Nature study on high‑induction risankizumab dosing.…

Leave a Reply